Search research articles
Contact Us
Filters
Showing results (191-200 of 264) with videos related to
Page
of 27
Sort By:
European Journal of Nuclear Medicine
|
April 17, 2001
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma
R Fonti, S Del Vecchio, A Zannetti, et al.
Pharmaceutics
|
October 27, 2022
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
Simona Camorani, Silvia Tortorella, Lisa Agnello, et al.
Annals of Hematology
|
July 19, 2013
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes
Lucia Pantani, Elena Zamagni, Beatrice Anna Zannetti, et al.
Expert Review of Hematology
|
December 5, 2015
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma
L Pantani, A Brioli, P Tacchetti, et al.
Theranostics
|
September 16, 2017
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
Simona Camorani, Billy Samuel Hill, Raffaela Fontanella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2008
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3
Antonella Zannetti, Francesca Iommelli, Rosa Fonti, et al.
The Journal of Biological Chemistry
|
August 19, 2007
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells
Patrizia Caposio, Francesca Gugliesi, Claudia Zannetti, et al.
Bone Marrow Transplantation
|
January 11, 2012
Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease
A Brioli, E Zamagni, S Pasquali, et al.
Cell Communication and Signaling : CCS
|
February 10, 2025
A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling
Ylenia Ferrara, Debora Latino, Angela Costagliola di Polidoro, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 5, 2016
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma
Adelaide Greco, Sandra Albanese, Luigi Auletta, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 264) with videos related to
Sort By:
Page
of 27
European Journal of Nuclear Medicine
|
April 17, 2001
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma
R Fonti, S Del Vecchio, A Zannetti, et al.
Pharmaceutics
|
October 27, 2022
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
Simona Camorani, Silvia Tortorella, Lisa Agnello, et al.
Annals of Hematology
|
July 19, 2013
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes
Lucia Pantani, Elena Zamagni, Beatrice Anna Zannetti, et al.
Expert Review of Hematology
|
December 5, 2015
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma
L Pantani, A Brioli, P Tacchetti, et al.
Theranostics
|
September 16, 2017
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
Simona Camorani, Billy Samuel Hill, Raffaela Fontanella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2008
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3
Antonella Zannetti, Francesca Iommelli, Rosa Fonti, et al.
The Journal of Biological Chemistry
|
August 19, 2007
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells
Patrizia Caposio, Francesca Gugliesi, Claudia Zannetti, et al.
Bone Marrow Transplantation
|
January 11, 2012
Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease
A Brioli, E Zamagni, S Pasquali, et al.
Cell Communication and Signaling : CCS
|
February 10, 2025
A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling
Ylenia Ferrara, Debora Latino, Angela Costagliola di Polidoro, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 5, 2016
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma
Adelaide Greco, Sandra Albanese, Luigi Auletta, et al.
Page
of 27